T1	Condition 20 42	pneumococcal infection
T2	Procedure 0 11	Vaccination
R1	AND Arg1:T2 Arg2:T1	
T3	Drug 73 104	preparations of immune globulin
T4	Procedure 108 125	blood transfusion
T5	Temporal 126 176	within last three months prior to clinical studies
*	OR T3 T4
T6	Scope 73 125	preparations of immune globulin or blood transfusion
R2	Has_temporal Arg1:T6 Arg2:T5	
T7	Temporal 194 211	more than 14 days
T8	Temporal 179 192	Prolonged use
R3	Subsumes Arg1:T8 Arg2:T7	
T9	Drug 213 231	immunosuppressants
T10	Qualifier 235 240	other
T11	Drug 241 264	immunosuppressive drugs
R4	Has_qualifier Arg1:T11 Arg2:T10	
*	OR T9 T11
T12	Temporal 265 312	within 6 months prior to the start of the study
T13	Scope 213 264	immunosuppressants or other immunosuppressive drugs
R5	Has_temporal Arg1:T13 Arg2:T8	
R6	Has_temporal Arg1:T13 Arg2:T12	
T14	Condition 342 359;379 388	immunosuppressive condition
T15	Condition 363 388	immunodeficient condition
*	OR T15 T14
T16	Condition 400 413	HIV infection
T17	Scope 342 388	immunosuppressive or immunodeficient condition
R7	Subsumes Arg1:T17 Arg2:T16	
T18	Non-representable 416 469	A history or currently hematologic and other cancers;
T19	Measurement 482 508	reaction for HIV infection
T20	Value 473 481	positive
T21	Measurement 482 494;510 527	reaction for viral hepatitis B
T22	Measurement 482 494;532 543	reaction for hepatitis C
*	OR T21 T22 T19
T23	Scope 482 543	reaction for HIV infection, viral hepatitis B and hepatitis C
R8	Has_value Arg1:T23 Arg2:T20	
T24	Condition 575 604	cardio-vascular insufficiency
T25	Condition 562 573;591 604	respiratory insufficiency
T26	Condition 606 620	impaired liver
T27	Condition 606 614;625 640	impaired kidney function
*	OR T27 T26 T25 T24
T28	Temporal 684 701	at visit number 1
T29	Scope 562 640	respiratory, cardio-vascular insufficiency, impaired liver and kidney function
R9	Has_temporal Arg1:T29 Arg2:T28	
T30	Condition 715 733	congenital defects
T31	Condition 745 761	chronic diseases
T32	Qualifier 769 780	acute stage
R10	Has_qualifier Arg1:T31 Arg2:T32	
*	OR T30 T31
T33	Qualifier 796 816	clinically important
T34	Qualifier 737 744	serious
R11	Has_qualifier Arg1:T31 Arg2:T34	
T35	Condition 817 829	exacerbation
T36	Condition 841 862	diseases of the liver
T37	Qualifier 833 840	chronic
T38	Condition 841 856;864 870	diseases of the kidney
T39	Condition 841 856;872 886;896 902	diseases of the cardiovascular system
T40	Condition 841 856;888 902	diseases of the nervous system
T41	Condition 904 919	mental diseases
T42	Condition 923 942	metabolic disorders
T43	Condition 1006 1021	cystic fibrosis
T44	Condition 1023 1035	lung abscess
T45	Condition 1037 1044	empyema
T46	Qualifier 1046 1052	active
T47	Condition 1053 1065	tuberculosis
R12	Has_qualifier Arg1:T47 Arg2:T46	
T48	Condition 1084 1108	congestive heart failure
T49	Condition 1110 1123	malabsorption
T50	Condition 1143 1158	hepatic failure
T51	Condition 1133 1138;1151 1158	renal failure
T52	Qualifier 1125 1132	chronic
T53	Scope 1133 1158	renal and hepatic failure
R13	Has_qualifier Arg1:T53 Arg2:T52	
T54	Condition 1160 1169	cirrhosis
T55	Condition 1171 1181	malignancy
T56	Condition 1183 1199	immunodeficiency
T57	Condition 1201 1223	cirrhosis of the liver
*	OR T56 T57 T55 T54 T53 T49 T48 T47 T45 T44 T43
T58	Scope 995 1223	pulmonary: cystic fibrosis, lung abscess, empyema, active tuberculosis; extra-pulmonary: congestive heart failure, malabsorption, chronic renal and hepatic failure, cirrhosis, malignancy, immunodeficiency, cirrhosis of the liver
*	OR T42 T41 T59 T35
T59	Scope 841 902	diseases of the liver, kidney, cardiovascular, nervous system
R14	Has_qualifier Arg1:T59 Arg2:T37	
T60	Scope 817 942	exacerbation of chronic diseases of the liver, kidney, cardiovascular, nervous system, mental diseases or metabolic disorders
R15	Has_qualifier Arg1:T60 Arg2:T33	
R16	Subsumes Arg1:T59 Arg2:T58	
T61	Scope 715 780	congenital defects or serious chronic diseases in the acute stage
R17	Subsumes Arg1:T61 Arg2:T59	
T62	Qualifier 1227 1233	Severe
T63	Condition 1234 1252	allergic reactions
R18	Has_qualifier Arg1:T63 Arg2:T62	
T64	Qualifier 1306 1311	acute
T65	Condition 1312 1322;1343 1352	infectious illnesses
T66	Condition 1330 1352	communicable illnesses
T67	Temporal 1353 1382	within 1 month prior to study
T68	Scope 1312 1352	infectious and/or communicable illnesses
R19	Has_qualifier Arg1:T68 Arg2:T64	
R20	Has_temporal Arg1:T68 Arg2:T67	
T69	Condition 1404 1417	alcohol abuse
T70	Condition 1425 1433	drug use
T71	Qualifier 1396 1403	chronic
*	OR T69 T70
T72	Scope 1404 1433	alcohol abuse and/or drug use
R21	Has_qualifier Arg1:T72 Arg2:T71	
T73	Condition 1436 1448	Exacerbation
T74	Condition 1452 1468	chronic diseases
R22	AND Arg1:T73 Arg2:T74	
T75	Observation 1471 1484	Breastfeeding
T76	Condition 1487 1496	Pregnancy
T77	Observation 1499 1515;1526 1540	Participation in clinical study
T78	Qualifier 1516 1525	any other
T79	Temporal 1541 1565	within the last 3 months
R23	Has_qualifier Arg1:T77 Arg2:T78	
R24	Has_temporal Arg1:T77 Arg2:T79	
T80	Reference_point 1377 1382	study
R25	Has_index Arg1:T67 Arg2:T80	
